Divergence Entropy-Based Evaluation of Hydrophobic Core in Aggressive and Resistant Forms of Transthyretin
暂无分享,去创建一个
Irena Roterman-Konieczna | Mateusz Banach | Leszek Konieczny | Katarzyna Stapor | Piotr Fabian | M. Banach | L. Konieczny | I. Roterman-Konieczna | K. Stapor | Piotr Fabian
[1] G. Chiellini,et al. Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer’s Disease? , 2020, International journal of molecular sciences.
[2] V. Daggett,et al. Edge strand dissociation and conformational changes in transthyretin under amyloidogenic conditions. , 2020, Biophysical journal.
[3] I. Roterman,et al. The Structure of Amyloid Versus the Structure of Globular Proteins , 2020, International journal of molecular sciences.
[4] Irena Roterman-Konieczna,et al. The Status of Edge Strands in Ferredoxin-Like Fold , 2020, Symmetry.
[5] I. Roterman,et al. Model of Early Stage Intermediate in Respect to Its Final Structure , 2019, Biomolecules.
[6] Mateusz Banach,et al. The Amyloid as a Ribbon-Like Micelle in Contrast to Spherical Micelles Represented by Globular Proteins , 2019, Molecules.
[7] V. Daggett,et al. Drivers of α-sheet formation in transthyretin under amyloidogenic conditions. , 2019, Biochemistry.
[8] I. Hung,et al. Two distinct aggregation pathways in transthyretin misfolding and amyloid formation. , 2019, Biochimica et biophysica acta. Proteins and proteomics.
[9] B. L. de Groot,et al. A molecular mechanism for transthyretin amyloidogenesis , 2019, Nature Communications.
[10] D. Eisenberg,et al. Crystal structures of amyloidogenic segments of human transthyretin , 2018, Protein science : a publication of the Protein Society.
[11] F. Fogolari,et al. Dynamics and Thermodynamics of Transthyretin Association from Molecular Dynamics Simulations , 2018, BioMed research international.
[12] J. Kelly,et al. Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation. , 2017, Biochemistry.
[13] David A. Lee,et al. CATH: an expanded resource to predict protein function through structure and sequence , 2016, Nucleic Acids Res..
[14] Duilio Cascio,et al. Uncovering the Mechanism of Aggregation of Human Transthyretin , 2015, The Journal of Biological Chemistry.
[15] Irena Roterman-Konieczna,et al. Application of Divergence Entropy to Characterize the Structure of the Hydrophobic Core in DNA Interacting Proteins , 2015, Entropy.
[16] M. Vieira,et al. Transthyretin: a multifaceted protein , 2014, Biomolecular concepts.
[17] A. Martinelli,et al. Computational studies on transthyretin. , 2012, Current medicinal chemistry.
[18] M. Saraiva,et al. Transthyretin: roles in the nervous system beyond thyroxine and retinol transport , 2012, Expert review of endocrinology & metabolism.
[19] Michele Vendruscolo,et al. Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility , 2011, Proceedings of the National Academy of Sciences.
[20] B. Volkman,et al. Native-state interconversion of a metamorphic protein requires global unfolding. , 2011, Biochemistry.
[21] M. Sousa,et al. Aboard transthyretin: From transport to cleavage , 2010, IUBMB life.
[22] Cândida G. Silva,et al. Potentially amyloidogenic conformational intermediates populate the unfolding landscape of transthyretin: Insights from molecular dynamics simulations , 2010, Protein science : a publication of the Protein Society.
[23] J. Buxbaum,et al. Transthyretin: the servant of many masters , 2009, Cellular and Molecular Life Sciences.
[24] Gianluca Pollastri,et al. Structural alphabets for protein structure classification: a comparison study. , 2009, Journal of molecular biology.
[25] E. Génin,et al. On the Origin of the Transthyretin Val30Met Familial Amyloid Polyneuropathy , 2008, Annals of human genetics.
[26] J. Kelly,et al. Human-Murine Transthyretin Heterotetramers Are Kinetically Stable and Non-amyloidogenic , 2008, Journal of Biological Chemistry.
[27] John D. Hunter,et al. Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.
[28] A. Esteras-Chopo,et al. Early kinetics of amyloid fibril formation reveals conformational reorganisation of initial aggregates. , 2007, Journal of molecular biology.
[29] Fabrizio Chiti,et al. Sequence and structural determinants of amyloid fibril formation. , 2006, Accounts of chemical research.
[30] C. Dobson,et al. Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.
[31] J. Kelly,et al. Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. , 2005, Biochemistry.
[32] Mark D. Fox,et al. The "slip". , 2005, The virtual mentor : VM.
[33] M. Lei,et al. Initial conformational changes of human transthyretin under partially denaturing conditions. , 2005, Biophysical journal.
[34] U. W. Hultdin,et al. The effect of iodide and chloride on transthyretin structure and stability. , 2005, Biochemistry.
[35] J. Prausnitz,et al. Amyloid fibril formation by peptide LYS (11-36) in aqueous trifluoroethanol. , 2004, Biomacromolecules.
[36] Leszek Konieczny,et al. Conformational subspace in simulation of early‐stage protein folding , 2004, Proteins.
[37] S. Wijmenga,et al. Probing Solvent Accessibility of Transthyretin Amyloid by Solution NMR Spectroscopy* , 2004, Journal of Biological Chemistry.
[38] C. Dobson,et al. Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme , 2002, Nature Structural Biology.
[39] Joana Almeida Palha,et al. Transthyretin as a Thyroid Hormone Carrier: Function Revisited , 2002, Clinical chemistry and laboratory medicine.
[40] J. Hamilton,et al. Transthyretin: a review from a structural perspective , 2001, Cellular and Molecular Life Sciences CMLS.
[41] H. M. Petrassi,et al. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. , 2001, Biochemistry.
[42] Rui M. M. Brito,et al. Tetramer Dissociation and Monomer Partial Unfolding Precedes Protofibril Formation in Amyloidogenic Transthyretin Variants* , 2001, The Journal of Biological Chemistry.
[43] D. Wemmer,et al. A glimpse of a possible amyloidogenic intermediate of transthyretin , 2000, Nature Structural Biology.
[44] C. Dobson,et al. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. , 1998, Journal of molecular biology.
[45] I Roterman,et al. Modelling the optimal simulation path in the peptide chain folding--studies based on geometry of alanine heptapeptide. , 1995, Journal of theoretical biology.
[46] J. Kelly,et al. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. , 1992, Biochemistry.
[47] M. Skinner,et al. Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with familial amyloid polyneuropathy. , 1984, Molecular biology & medicine.
[48] M. Levitt. A simplified representation of protein conformations for rapid simulation of protein folding. , 1976, Journal of molecular biology.
[49] C. Anfinsen. Principles that govern the folding of protein chains. , 1973, Science.
[50] R. A. Leibler,et al. On Information and Sufficiency , 1951 .
[51] Mateusz Banach,et al. SUPPLEMENT A , 2020 .
[52] I. Roterman,et al. Information encoded in protein structure , 2020 .
[53] I. Roterman,et al. Anti-amyloid drug design , 2020, From Globular Proteins to Amyloids.
[54] I. Roterman,et al. Description of the fuzzy oil drop model , 2020, From Globular Proteins to Amyloids.
[55] Irena Roterman-Konieczna,et al. The early-stage intermediate , 2012 .
[56] D. Small,et al. Mechanisms of transthyretin aggregation and toxicity. , 2012, Sub-cellular biochemistry.
[57] C. E. Fleming,et al. Chapter 17: Transthyretin: an enhancer of nerve regeneration. , 2009, International review of neurobiology.
[58] Irena Roterman-Konieczna,et al. Gauss-Function-Based Model of Hydrophobicity Density in Proteins , 2006, Silico Biol..
[59] D. Teplow,et al. Kinetic studies of amyloid beta-protein fibril assembly. Differential effects of alpha-helix stabilization. , 2002, The Journal of biological chemistry.
[60] Scott A. Peterson,et al. Transthyretin quaternary and tertiary structural changes facilitate misassembly into amyloid. , 1997, Advances in protein chemistry.
[61] L. Serpell,et al. The "edge strand" hypothesis: Prediction and test of a mutational "hot-spot" on the transthyretin molecule associated with FAP amyloidogenesis , 1996 .
[62] I Roterman,et al. The geometrical analysis of peptide backbone structure and its local deformations. , 1995, Biochimie.
[63] H. Berman,et al. The Protein Data Bank. , 2002, Acta crystallographica. Section D, Biological crystallography.